Development and Characterization of the NISTCHO Reference Cell Line
Biotechnology Journal · 2025
DOI: 10.1002/biot.70012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2025. Verfasst von Hussain Dahodwala und 19 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Innovation in Manufacturing Biopharmaceuticals, University of Delaware, Newark, Delaware, USA. Hauptthemen laut MEDLINE: Immunoglobulin G. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Well‐characterized reference materials enable successful collaborations within the scientific community by establishing common reagents for benchmarking studies and reducing the barriers to sharing materials and information. Here, we report the development of NISTCHO, a recombinant Chinese hamster ovary cell line expressing a nonoriginator version of the NISTmAb IgG1. We evaluated candidate clonal cell lines in a fed‐batch cell culture model to assess growth and productivity of the cell lines and protein quality attributes of the recombinant IgG produced, which demonstrated suitability of multiple candidates. Selection of a preferred candidate was accomplished through sequencing‐based analysis of the transgene integration sites, and a base‐pair resolution map of the transgene integration site was developed and verified using PCR‐based methods. Lastly, a validation study performed by an independent laboratory confirmed the robustness of the preferred candidate, which has been selected for further development as the NISTCHO reference cell line. Together, these results describe the origin of this new reference material and will serve as the foundation for future interlaboratory studies using the NISTCHO cell line.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute for Innovation in Manufacturing Biopharmaceuticals, University of Delaware, Newark, Delaware, USA.
- Process Solutions, MilliporeSigma, St. Louis, Missouri, USA.
- Life Science Services, MilliporeSigma, Rockville, Maryland, USA.
- Central Analytics, MilliporeSigma, St. Louis, Missouri, USA.
- Bioinformatics, IT R&D Applications, Sigma-Aldrich Chemicals Pvt. Ltd., A subsidiary of Merck KGaA, Darmstadt, Germany, Bangalore, India.
- Bioinformatics, Analytics Center of Excellence, MilliporeSigma, St. Louis, Missouri, USA.
ORCID-Profile: Trissa Borgschulte, Kelvin H Lee, Zvi Kelman, Britta A Anderson
Zitieren
APA
Dahodwala, H., Hodzic, I., Slesarev, A., Cutak, B., Kuzin, A., Lal, R., Liu, J., Mahon, J., Narasimhan, R. L., Onuska, J., Ravellette, J., Reger, K., Sakurada, S., Stewart, F., Borgschulte, T., Cote, C., Lee, K. H., O'Dell, W. B., Kelman, Z., & Anderson, B. A. (2025). Development and Characterization of the NISTCHO Reference Cell Line. Biotechnology Journal. https://doi.org/10.1002/biot.70012
Vancouver
Dahodwala H, Hodzic I, Slesarev A, Cutak B, Kuzin A, Lal R, et al. Development and Characterization of the NISTCHO Reference Cell Line. Biotechnology Journal. 2025. doi:10.1002/biot.70012
BibTeX
@article{Dahodwala2025,
author = {Dahodwala, Hussain and Hodzic, Irfan and Slesarev, Alexei and Cutak, Benjamin and Kuzin, Alexander and Lal, Rahul and Liu, Jiajian and Mahon, James and Narasimhan, Rajagopalan Lakshmi and Onuska, Jaya and Ravellette, James and Reger, Kelsey and Sakurada, Sadie and Stewart, Floy and Borgschulte, Trissa and Cote, Colette and Lee, Kelvin H and O'Dell, William B and Kelman, Zvi and Anderson, Britta A},
title = {Development and Characterization of the NISTCHO Reference Cell Line},
journal = {Biotechnology Journal},
year = {2025},
doi = {10.1002/biot.70012}
}
EUVIMED